Trials / Recruiting
RecruitingNCT05416567
Embolization for Meningioma
Therapeutic Endovascular Embolization for Intracranial Meningioma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- St. Olavs Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but there is a significant risk of adverse effects. Stereotactic radiotherapy is most often reserved to treat relapses after surgery, and except for surgery and radiotherapy there are no other established treatment methods. Endovascular embolization may be used in selected cases as a preoperative adjunct to reduce intraoperative bleeding. There is a need for more treatment options in patients with meningioma, both in uncomplicated, asymptomatic cases and in more complex cases. The aim of this study is to assess radiological and clinical results of therapeutic endovascular embolization for meningioma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endovascular embolization | Therapeutic endovascular embolization in general anesthesia |
Timeline
- Start date
- 2022-10-10
- Primary completion
- 2027-08-01
- Completion
- 2037-08-01
- First posted
- 2022-06-13
- Last updated
- 2025-06-05
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT05416567. Inclusion in this directory is not an endorsement.